IBDEI0CW ; ; 03-MAY-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32356,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,32356,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,32357,0)
 ;;=L25.9^^97^1335^15
 ;;^UTILITY(U,$J,358.3,32357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32357,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,32357,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,32357,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,32358,0)
 ;;=L40.0^^97^1335^16
 ;;^UTILITY(U,$J,358.3,32358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32358,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,32358,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,32358,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,32359,0)
 ;;=L29.9^^97^1335^17
 ;;^UTILITY(U,$J,358.3,32359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32359,1,3,0)
 ;;=3^Pruritus
 ;;^UTILITY(U,$J,358.3,32359,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,32359,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,32360,0)
 ;;=L85.3^^97^1335^18
 ;;^UTILITY(U,$J,358.3,32360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32360,1,3,0)
 ;;=3^Xerosis
 ;;^UTILITY(U,$J,358.3,32360,1,4,0)
 ;;=4^L85.3
 ;;^UTILITY(U,$J,358.3,32360,2)
 ;;=^5009323
 ;;^UTILITY(U,$J,358.3,32361,0)
 ;;=L30.2^^97^1335^19
 ;;^UTILITY(U,$J,358.3,32361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32361,1,3,0)
 ;;=3^Cutaneous Autosensitization/ld
 ;;^UTILITY(U,$J,358.3,32361,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,32361,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,32362,0)
 ;;=L72.0^^97^1335^20
 ;;^UTILITY(U,$J,358.3,32362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32362,1,3,0)
 ;;=3^Epidermal Cyst
 ;;^UTILITY(U,$J,358.3,32362,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,32362,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,32363,0)
 ;;=L73.9^^97^1335^21
 ;;^UTILITY(U,$J,358.3,32363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32363,1,3,0)
 ;;=3^Follicular Disorder/Folliculitis
 ;;^UTILITY(U,$J,358.3,32363,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,32363,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,32364,0)
 ;;=L70.0^^97^1335^22
 ;;^UTILITY(U,$J,358.3,32364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32364,1,3,0)
 ;;=3^Acne
 ;;^UTILITY(U,$J,358.3,32364,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,32364,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,32365,0)
 ;;=L71.8^^97^1335^23
 ;;^UTILITY(U,$J,358.3,32365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32365,1,3,0)
 ;;=3^Rosacea
 ;;^UTILITY(U,$J,358.3,32365,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,32365,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,32366,0)
 ;;=L91.0^^97^1335^24
 ;;^UTILITY(U,$J,358.3,32366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32366,1,3,0)
 ;;=3^Hypertrophic Scar
 ;;^UTILITY(U,$J,358.3,32366,1,4,0)
 ;;=4^L91.0
 ;;^UTILITY(U,$J,358.3,32366,2)
 ;;=^5009459
 ;;^UTILITY(U,$J,358.3,32367,0)
 ;;=L91.8^^97^1335^25
 ;;^UTILITY(U,$J,358.3,32367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32367,1,3,0)
 ;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
 ;;^UTILITY(U,$J,358.3,32367,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,32367,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,32368,0)
 ;;=I87.2^^97^1335^26
 ;;^UTILITY(U,$J,358.3,32368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32368,1,3,0)
 ;;=3^Stasis Dermatitis/Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,32368,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,32368,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,32369,0)
 ;;=D69.8^^97^1335^27
 ;;^UTILITY(U,$J,358.3,32369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32369,1,3,0)
 ;;=3^Purpura,Hemorrhagic Condition
 ;;^UTILITY(U,$J,358.3,32369,1,4,0)
 ;;=4^D69.8
 ;;^UTILITY(U,$J,358.3,32369,2)
 ;;=^88074
 ;;^UTILITY(U,$J,358.3,32370,0)
 ;;=L08.9^^97^1335^28
 ;;^UTILITY(U,$J,358.3,32370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32370,1,3,0)
 ;;=3^Pyoderma
 ;;^UTILITY(U,$J,358.3,32370,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,32370,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,32371,0)
 ;;=L01.00^^97^1335^29
 ;;^UTILITY(U,$J,358.3,32371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32371,1,3,0)
 ;;=3^Impetigo
 ;;^UTILITY(U,$J,358.3,32371,1,4,0)
 ;;=4^L01.00
 ;;^UTILITY(U,$J,358.3,32371,2)
 ;;=^5008938
 ;;^UTILITY(U,$J,358.3,32372,0)
 ;;=L03.90^^97^1335^30
 ;;^UTILITY(U,$J,358.3,32372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32372,1,3,0)
 ;;=3^Cellulitis
 ;;^UTILITY(U,$J,358.3,32372,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,32372,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,32373,0)
 ;;=Z79.1^^97^1335^31
 ;;^UTILITY(U,$J,358.3,32373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32373,1,3,0)
 ;;=3^Long Term Use NSAID/Oth Health Status
 ;;^UTILITY(U,$J,358.3,32373,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,32373,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,32374,0)
 ;;=Z79.899^^97^1335^32
 ;;^UTILITY(U,$J,358.3,32374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32374,1,3,0)
 ;;=3^Long Term Use Oth Drug
 ;;^UTILITY(U,$J,358.3,32374,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,32374,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,32375,0)
 ;;=Z80.8^^97^1335^33
 ;;^UTILITY(U,$J,358.3,32375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32375,1,3,0)
 ;;=3^Family Hx of Melanoma
 ;;^UTILITY(U,$J,358.3,32375,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,32375,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,32376,0)
 ;;=Z48.817^^97^1335^34
 ;;^UTILITY(U,$J,358.3,32376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32376,1,3,0)
 ;;=3^Surgical Aftercare Skin/Subcutaneous Tissue
 ;;^UTILITY(U,$J,358.3,32376,1,4,0)
 ;;=4^Z48.817
 ;;^UTILITY(U,$J,358.3,32376,2)
 ;;=^5063054
 ;;^UTILITY(U,$J,358.3,32377,0)
 ;;=R99.^^97^1335^35
 ;;^UTILITY(U,$J,358.3,32377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32377,1,3,0)
 ;;=3^Dead Unknown Mortality
 ;;^UTILITY(U,$J,358.3,32377,1,4,0)
 ;;=4^R99.
 ;;^UTILITY(U,$J,358.3,32377,2)
 ;;=^5019750
 ;;^UTILITY(U,$J,358.3,32378,0)
 ;;=Z85.9^^97^1335^36
 ;;^UTILITY(U,$J,358.3,32378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32378,1,3,0)
 ;;=3^Personal Hx of Unspec Neoplasm/Cancer
 ;;^UTILITY(U,$J,358.3,32378,1,4,0)
 ;;=4^Z85.9
 ;;^UTILITY(U,$J,358.3,32378,2)
 ;;=^5063452
 ;;^UTILITY(U,$J,358.3,32379,0)
 ;;=C79.9^^97^1335^37
 ;;^UTILITY(U,$J,358.3,32379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32379,1,3,0)
 ;;=3^Metastatic Cancer Unspec
 ;;^UTILITY(U,$J,358.3,32379,1,4,0)
 ;;=4^C79.9
 ;;^UTILITY(U,$J,358.3,32379,2)
 ;;=^5133344
 ;;^UTILITY(U,$J,358.3,32380,0)
 ;;=Q3014^^98^1336^1^^^^1
 ;;^UTILITY(U,$J,358.3,32380,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,32380,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,32380,1,3,0)
 ;;=3^Telehealth Fac Fee-Pt Site
 ;;^UTILITY(U,$J,358.3,32381,0)
 ;;=B19.10^^99^1337^1
 ;;^UTILITY(U,$J,358.3,32381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32381,1,3,0)
 ;;=3^Hepatitis B w/o Hepatic Coma
 ;;^UTILITY(U,$J,358.3,32381,1,4,0)
 ;;=4^B19.10
 ;;^UTILITY(U,$J,358.3,32381,2)
 ;;=^5000552
 ;;^UTILITY(U,$J,358.3,32382,0)
 ;;=B17.10^^99^1337^2
 ;;^UTILITY(U,$J,358.3,32382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32382,1,3,0)
 ;;=3^Hepatitis C w/o Hepatic Coma,Acute
 ;;^UTILITY(U,$J,358.3,32382,1,4,0)
 ;;=4^B17.10
 ;;^UTILITY(U,$J,358.3,32382,2)
 ;;=^5000542
 ;;^UTILITY(U,$J,358.3,32383,0)
 ;;=B18.2^^99^1337^3
 ;;^UTILITY(U,$J,358.3,32383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32383,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,32383,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,32383,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,32384,0)
 ;;=B35.6^^99^1337^4
 ;;^UTILITY(U,$J,358.3,32384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32384,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,32384,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,32384,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,32385,0)
 ;;=B35.3^^99^1337^5
 ;;^UTILITY(U,$J,358.3,32385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32385,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,32385,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,32385,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,32386,0)
 ;;=B97.89^^99^1337^6
 ;;^UTILITY(U,$J,358.3,32386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32386,1,3,0)
 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,32386,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,32386,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,32387,0)
 ;;=B02.9^^99^1337^7
 ;;^UTILITY(U,$J,358.3,32387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32387,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,32387,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,32387,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,32388,0)
 ;;=C44.91^^99^1338^1
 ;;^UTILITY(U,$J,358.3,32388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32388,1,3,0)
 ;;=3^Basal cell carcinoma of skin, unspecified
 ;;^UTILITY(U,$J,358.3,32388,1,4,0)
 ;;=4^C44.91
 ;;^UTILITY(U,$J,358.3,32388,2)
 ;;=^5001092
 ;;^UTILITY(U,$J,358.3,32389,0)
 ;;=D17.9^^99^1338^2
 ;;^UTILITY(U,$J,358.3,32389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32389,1,3,0)
 ;;=3^Benign lipomatous neoplasm, unspecified
 ;;^UTILITY(U,$J,358.3,32389,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,32389,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,32390,0)
 ;;=C67.9^^99^1338^3
 ;;^UTILITY(U,$J,358.3,32390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32390,1,3,0)
 ;;=3^Malignant neoplasm of bladder, unspecified
 ;;^UTILITY(U,$J,358.3,32390,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,32390,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,32391,0)
 ;;=C18.9^^99^1338^4
 ;;^UTILITY(U,$J,358.3,32391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32391,1,3,0)
 ;;=3^Malignant neoplasm of colon, unspecified
 ;;^UTILITY(U,$J,358.3,32391,1,4,0)
 ;;=4^C18.9
 ;;^UTILITY(U,$J,358.3,32391,2)
 ;;=^5000929
 ;;^UTILITY(U,$J,358.3,32392,0)
 ;;=C15.9^^99^1338^5
 ;;^UTILITY(U,$J,358.3,32392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32392,1,3,0)
 ;;=3^Malignant neoplasm of esophagus, unspecified
 ;;^UTILITY(U,$J,358.3,32392,1,4,0)
 ;;=4^C15.9
 ;;^UTILITY(U,$J,358.3,32392,2)
 ;;=^5000919
 ;;^UTILITY(U,$J,358.3,32393,0)
 ;;=C32.9^^99^1338^6
 ;;^UTILITY(U,$J,358.3,32393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32393,1,3,0)
 ;;=3^Malignant neoplasm of larynx, unspecified
 ;;^UTILITY(U,$J,358.3,32393,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,32393,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,32394,0)
 ;;=C34.92^^99^1338^7
 ;;^UTILITY(U,$J,358.3,32394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32394,1,3,0)
 ;;=3^Malignant neoplasm of left bronchus/lung,unspec part
 ;;^UTILITY(U,$J,358.3,32394,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,32394,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,32395,0)
 ;;=C50.912^^99^1338^8
 ;;^UTILITY(U,$J,358.3,32395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32395,1,3,0)
 ;;=3^Malignant neoplasm of left female breast,unspec site
 ;;^UTILITY(U,$J,358.3,32395,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,32395,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,32396,0)
 ;;=C64.2^^99^1338^9
 ;;^UTILITY(U,$J,358.3,32396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32396,1,3,0)
 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,32396,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,32396,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,32397,0)
 ;;=C61.^^99^1338^10
 ;;^UTILITY(U,$J,358.3,32397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32397,1,3,0)
 ;;=3^Malignant neoplasm of prostate
 ;;^UTILITY(U,$J,358.3,32397,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,32397,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,32398,0)
 ;;=C34.91^^99^1338^11
 ;;^UTILITY(U,$J,358.3,32398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32398,1,3,0)
 ;;=3^Malignant neoplasm of right bronchus/lung,unspec part
 ;;^UTILITY(U,$J,358.3,32398,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,32398,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,32399,0)
 ;;=C50.911^^99^1338^12
 ;;^UTILITY(U,$J,358.3,32399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32399,1,3,0)
 ;;=3^Malignant neoplasm of right female breast,unspec site
 ;;^UTILITY(U,$J,358.3,32399,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,32399,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,32400,0)
 ;;=C64.1^^99^1338^13
 ;;^UTILITY(U,$J,358.3,32400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32400,1,3,0)
 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,32400,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,32400,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,32401,0)
 ;;=C44.99^^99^1338^14
 ;;^UTILITY(U,$J,358.3,32401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32401,1,3,0)
 ;;=3^Malignant neoplasm of skin,Oth Spec
 ;;^UTILITY(U,$J,358.3,32401,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,32401,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,32402,0)
 ;;=C79.51^^99^1338^15
 ;;^UTILITY(U,$J,358.3,32402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32402,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,32402,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,32402,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,32403,0)
 ;;=C79.52^^99^1338^16
 ;;^UTILITY(U,$J,358.3,32403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32403,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone marrow
 ;;^UTILITY(U,$J,358.3,32403,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,32403,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,32404,0)
 ;;=D47.4^^99^1339^29
 ;;^UTILITY(U,$J,358.3,32404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32404,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,32404,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,32404,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,32405,0)
 ;;=D50.9^^99^1339^1
 ;;^UTILITY(U,$J,358.3,32405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32405,1,3,0)
 ;;=3^Anemia, iron deficiency
 ;;^UTILITY(U,$J,358.3,32405,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,32405,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,32406,0)
 ;;=D64.9^^99^1339^2
 ;;^UTILITY(U,$J,358.3,32406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32406,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,32406,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,32406,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,32407,0)
 ;;=D75.89^^99^1339^3
 ;;^UTILITY(U,$J,358.3,32407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32407,1,3,0)
 ;;=3^Blood & blood forming organ disease, oth spec
 ;;^UTILITY(U,$J,358.3,32407,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,32407,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,32408,0)
 ;;=D89.2^^99^1339^16
 ;;^UTILITY(U,$J,358.3,32408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32408,1,3,0)
 ;;=3^Hypergammaglobulinemia, unspecified
 ;;^UTILITY(U,$J,358.3,32408,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,32408,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,32409,0)
 ;;=E03.9^^99^1339^24
 ;;^UTILITY(U,$J,358.3,32409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32409,1,3,0)
 ;;=3^Hypothyroidism, unspecified
 ;;^UTILITY(U,$J,358.3,32409,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,32409,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,32410,0)
 ;;=E05.90^^99^1339^30
 ;;^UTILITY(U,$J,358.3,32410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32410,1,3,0)
 ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
 ;;^UTILITY(U,$J,358.3,32410,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,32410,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,32411,0)
 ;;=E08.42^^99^1339^10
 ;;^UTILITY(U,$J,358.3,32411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32411,1,3,0)
 ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,32411,1,4,0)
 ;;=4^E08.42
 ;;^UTILITY(U,$J,358.3,32411,2)
 ;;=^5002524
 ;;^UTILITY(U,$J,358.3,32412,0)
 ;;=E09.42^^99^1339^11
 ;;^UTILITY(U,$J,358.3,32412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32412,1,3,0)
 ;;=3^DM drug-induced w/ neurological compl w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,32412,1,4,0)
 ;;=4^E09.42
 ;;^UTILITY(U,$J,358.3,32412,2)
 ;;=^5002566
 ;;^UTILITY(U,$J,358.3,32413,0)
 ;;=E10.42^^99^1339^4
 ;;^UTILITY(U,$J,358.3,32413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32413,1,3,0)
 ;;=3^DM Type 1 w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,32413,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,32413,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,32414,0)
 ;;=E10.65^^99^1339^5
 ;;^UTILITY(U,$J,358.3,32414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32414,1,3,0)
 ;;=3^DM Type 1 w/ hyperglycemia
 ;;^UTILITY(U,$J,358.3,32414,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,32414,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,32415,0)
 ;;=E10.9^^99^1339^6
 ;;^UTILITY(U,$J,358.3,32415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32415,1,3,0)
 ;;=3^DM Type 1 w/o complications
 ;;^UTILITY(U,$J,358.3,32415,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,32415,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,32416,0)
 ;;=E11.42^^99^1339^7
 ;;^UTILITY(U,$J,358.3,32416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32416,1,3,0)
 ;;=3^DM Type 2 w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,32416,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,32416,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,32417,0)
 ;;=E11.65^^99^1339^8
 ;;^UTILITY(U,$J,358.3,32417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32417,1,3,0)
 ;;=3^DM Type 2 w/ hyperglycemia
 ;;^UTILITY(U,$J,358.3,32417,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,32417,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,32418,0)
 ;;=E11.9^^99^1339^9
 ;;^UTILITY(U,$J,358.3,32418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32418,1,3,0)
 ;;=3^DM Type 2 w/o complications
 ;;^UTILITY(U,$J,358.3,32418,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,32418,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,32419,0)
 ;;=E13.42^^99^1339^12
 ;;^UTILITY(U,$J,358.3,32419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32419,1,3,0)
 ;;=3^DM oth w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,32419,1,4,0)
 ;;=4^E13.42
 ;;^UTILITY(U,$J,358.3,32419,2)
 ;;=^5002686
 ;;^UTILITY(U,$J,358.3,32420,0)
 ;;=E16.2^^99^1339^22
 ;;^UTILITY(U,$J,358.3,32420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32420,1,3,0)
 ;;=3^Hypoglycemia, unspecified
 ;;^UTILITY(U,$J,358.3,32420,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,32420,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,32421,0)
 ;;=E46.^^99^1339^26
 ;;^UTILITY(U,$J,358.3,32421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32421,1,3,0)
 ;;=3^Malnutrition, protein-calorie, unspec
 ;;^UTILITY(U,$J,358.3,32421,1,4,0)
 ;;=4^E46.
 ;;^UTILITY(U,$J,358.3,32421,2)
 ;;=^5002790
 ;;^UTILITY(U,$J,358.3,32422,0)
 ;;=E53.8^^99^1339^31
 ;;^UTILITY(U,$J,358.3,32422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32422,1,3,0)
 ;;=3^Vitamin B group deficiency
 ;;^UTILITY(U,$J,358.3,32422,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,32422,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,32423,0)
 ;;=E66.01^^99^1339^27
 ;;^UTILITY(U,$J,358.3,32423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32423,1,3,0)
 ;;=3^Obesity, morbid
 ;;^UTILITY(U,$J,358.3,32423,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,32423,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,32424,0)
 ;;=E66.9^^99^1339^28
 ;;^UTILITY(U,$J,358.3,32424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32424,1,3,0)
 ;;=3^Obesity, unspecified
 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,32424,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,32425,0)
 ;;=E74.39^^99^1339^25
 ;;^UTILITY(U,$J,358.3,32425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
 ;;=3^Intestinal carbohydrate absorption disorder, other
